THE Chemo-sero-therapeutic Research Institute
USPTO PatentsView assignee record - 23 granted patents across 15 technology areas, recorded in grant years 2015–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, THE ranks #13,194 of 49,997 tracked US assignees by granted-patent volume, with 23 patents across 15 technology areas.
- #13,194
- of 49,997 US assignees by volume
- 43rd percentile
- by Innovation Score (32.9/100)
- 13.7
- avg claims per patent
- -95%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R13194 · Foreign Corporation #13,194 · 23 grants
GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL
- GRANTS-SMALL 23 grants
- MID-PACK #13,194/49,997
- PHOTO-FINISH Teco Electric &…
- CPC-FOCUS A61P · 15 areas
- INNOV-THIN 32.9/100
- CLAIMS-RICH 13.7 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-DROP -95% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Teco Electric & Machinery Co., Ltd. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How THE’s 32.9 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around THE
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- THE Chemo-sero-thera… · this assignee 33
THE Chemo-sero-thera… · this assignee
33 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows THE's Innovation Score is 32.9/100 (43rd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for THE?
Each dot is one of THE’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). THE’s own 13.7 claims/patent is ABOVE the 11.9 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where THE's grants concentrate
THE Chemo-sero-therapeutic Research Institute is a focused PatentsView assignee: 15 CPC subclasses with 82.6% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2015 (8 grants) versus a trough of 1 in 2020. By volume, THE sits between Teco Electric & Machinery Co., Ltd. and Tilta Inc..
Who files at THE's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Teco Electric & M…
Teco Electric & Machinery Co., Ltd.
23 patents
- TGW Mechanics
TGW Mechanics GmbH
23 patents
- Thales DIS AIS De…
Thales DIS AIS Deutschland GMBH
23 patents
- Thales DIS CPL USA
Thales DIS CPL USA, Inc.
23 patents
- THE Hartz Mountain
THE Hartz Mountain Corp
23 patents
- Thyssenkrupp Carb…
Thyssenkrupp Carbon Components GMBH
23 patents
- Tianjin Institute…
Tianjin Institute OF Industrial Biotechnology, Chinese Academy OF Sciences
23 patents
- Tilta
Tilta Inc.
23 patents
- THE Chemo-sero-th… ◀
THE Chemo-sero-therapeutic Research Institute
23 patents
What this shows THE holds 23 patents at rank #13,184, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near THE
By rank, the assignees closest to #13,184 in granted patent volume.
- Teco Electric & Machinery Co., Ltd. #13,180 · 23 patents
- TGW Mechanics GmbH #13,181 · 23 patents
- Thales DIS AIS Deutschland GMBH #13,182 · 23 patents
- Thales DIS CPL USA, Inc. #13,183 · 23 patents
- THE Hartz Mountain Corp #13,185 · 23 patents
- Thyssenkrupp Carbon Components GMBH #13,186 · 23 patents
- Tianjin Institute OF Industrial Biotechnology, Chinese Academy OF Sciences #13,187 · 23 patents
- Tilta Inc. #13,188 · 23 patents
Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)
Other assignees with the most granted patents in THE's primary technology class.
- The Regents of the University of California 1,387 in class
- Novartis AG 1,071 in class
- Merck Sharp & Dohme LLC 889 in class
- Bristol-Myers Squibb Company 879 in class
- Genentech, Inc. 789 in class
- The Board of Regents of the University of Texas System 744 in class
- Hoffmann-La Roche Inc. 722 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 721 in class
THE's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
33 43rd percentile higher than 43% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 8 | 34.8% |
| 2016 | 2 | 8.7% |
| 2017 | 7 | 30.4% |
| 2018 | 2 | 8.7% |
| 2019 | 3 | 13.0% |
| 2020 | 1 | 4.3% |
Which technologies does THE Chemo-sero-therapeutic Research Institute patent most?
Top 15 of 15 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
THE Chemo-sero-therapeutic Research Institute's patent record in context - here's where to go next.
- THE Chemo-sero-therapeutic Research Institute's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 82.6% of its portfolio - see every assignee active in that class. Explore A61P
- Ranked #13,194 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare THE Chemo-sero-therapeutic Research Institute against Teco Electric & Machinery Co., Ltd., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 32.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.